Royalty Pharma plc (RPRX) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es ADAGE CAPITAL PARTNERS GP, L.L.C. con 38,815,330 acciones. Otros tenedores destacados incluyen GG 1978 SICAF SIF S.A. y GG 1978 SICAF SIF S.A. - GG Strategic.
En los últimos 12 meses, los internos han realizado 80 transacciones en RPRX acciones — 41 compras (valoradas en $187.39K) y 28 ventas (valoradas en $20.79M). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
RPRX Participación de Insiders
Principal Titular
ADAGE CAPITAL PARTNERS GP, L.L.C.
38,815,330 acciones
Compras (12 meses)
41
$187.39K valor
Ventas (12 meses)
28
$20.79M valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Adage Capital Partners Gp, L.l.c. |
10 Percent Owner |
38,815,330 |
2020-12-18 |
|
| 2 |
Gg 1978 Sicaf Sif S.a. |
Officer |
22,235,310 |
2022-09-16 |
|
| 3 |
Gg 1978 Sicaf Sif S.a. - Gg Strategic |
Officer |
21,426,170 |
2022-09-22 |
|
| 4 |
Efficacy Capital, Ltd. |
10 Percent Owner |
2,658,936 |
2009-12-21 |
|
| 5 |
Avara Management Ltd |
10 Percent Owner |
2,477,520 |
2024-01-03 |
|
| 6 |
Oliveira Steven Michael |
10 Percent Owner |
1,315,672 |
2011-04-26 |
|
| 7 |
Legorreta Pablo G. |
CEO, Chairman of the Board |
1,098,783 |
2026-02-13 |
|
| 8 |
Hite Christopher |
EVP & Vice Chairman |
685,136 |
2026-02-13 |
|
| 9 |
Reddoch James F. |
EVP & Chief Scientific Officer |
478,870 |
2022-09-30 |
|
| 10 |
Riggs Rory B |
Director |
270,000 |
2024-02-22 |
|
| 11 |
Norden Gregory |
Director |
194,848 |
2025-08-11 |
|
| 12 |
Desouza Errol B |
Director |
81,352 |
2025-05-14 |
|
| 13 |
Bassler Bonnie L |
Director |
73,947 |
2026-03-31 |
|
| 14 |
Fernandez Henry A |
Director |
65,324 |
2025-06-30 |
|
| 15 |
Love Ted W |
Director |
53,848 |
2025-05-14 |
|
| 16 |
Engelbert Catherine M. |
Director |
51,128 |
2025-05-15 |
|
| 17 |
Hodgson David C |
Director |
33,328 |
2025-05-14 |
|
| 18 |
Coyne Terrance P. |
EVP & CFO |
32,916 |
2026-04-02 |
|
| 19 |
Lloyd George W. |
EVP, Investments & CLO |
30,654 |
2025-12-19 |
|
| 20 |
Ramasastry Saira |
Director |
27,779 |
2018-01-31 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-04-01 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
32,916 |
$48.33 |
$1.59M |
| 2026-03-31 |
Bassler Bonnie L |
Director |
Concesión de RSU |
815 |
$45.98 |
$37.47K |
| 2026-03-23 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
1,875 |
$45.53 |
$85.37K |
| 2026-03-02 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
583 |
$47.01 |
$27.41K |
| 2026-02-23 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
1,875 |
$45.32 |
$84.97K |
| 2026-02-11 |
Urist Marshall |
EVP, Research & Investments |
Concesión de RSU |
19,970 |
- |
- |
| 2026-02-11 |
Coyne Terrance P. |
EVP & CFO |
Concesión de RSU |
26,626 |
- |
- |
| 2026-02-11 |
Hite Christopher |
EVP & Vice Chairman |
Concesión de RSU |
26,626 |
- |
- |
| 2026-02-11 |
Legorreta Pablo G. |
CEO, Chairman of the Board |
Concesión de RSU |
157,828 |
- |
- |
| 2026-02-04 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
1,087 |
$43.29 |
$47.06K |
| 2026-02-03 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
6,195 |
$42.84 |
$265.41K |
| 2026-02-02 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
5,843 |
$42.08 |
$245.9K |
| 2026-01-30 |
Urist Marshall |
EVP, Research & Investments |
Venta Informativa |
20,000 |
$41.09 |
$821.81K |
| 2026-01-23 |
Urist Marshall |
EVP, Research & Investments |
Venta Informativa |
20,000 |
$40.26 |
$805.11K |
| 2026-01-20 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
3,750 |
$39.35 |
$147.56K |
| 2026-01-16 |
Urist Marshall |
EVP, Research & Investments |
Venta Informativa |
20,000 |
$39.52 |
$790.35K |
| 2026-01-09 |
Urist Marshall |
EVP, Research & Investments |
Venta Informativa |
20,000 |
$40.78 |
$815.63K |
| 2026-01-01 |
Mcgivern Arthur Richard |
EVP, Investments & Gc |
Desconocido |
706,393 |
- |
- |
| 2026-01-02 |
Urist Marshall |
EVP, Research & Investments |
Venta Informativa |
20,000 |
$38.48 |
$769.65K |
| 2026-01-02 |
Coyne Terrance P. |
EVP & CFO |
Venta Informativa |
3,750 |
$38.42 |
$144.06K |
| 2025-12-31 |
Bassler Bonnie L |
Director |
Concesión de RSU |
967 |
$38.74 |
$37.46K |
| 2025-12-26 |
Urist Marshall |
EVP, Research & Investments |
Venta Informativa |
20,000 |
$39.32 |
$786.38K |
| 2025-12-19 |
Urist Marshall |
EVP, Research & Investments |
Venta Informativa |
20,000 |
$38.38 |
$767.58K |
| 2025-12-18 |
Lloyd George W. |
EVP, Investments & CLO |
Venta Informativa |
30,654 |
$38.50 |
$1.18M |
| 2025-12-17 |
Lloyd George W. |
EVP, Investments & CLO |
Venta Informativa |
79,346 |
$38.57 |
$3.06M |
